Carolin Kitzberger

Selective sodium iodide symporter (NIS) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes

E. Wagner, W. Weber, P. Nelson, 2021, Molecular therapy oncolytics.

Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell–Mediated Sodium Iodide Symporter (NIS) Gene 131I Therapy

M. Schwaiger, T. Biedermann, E. Wagner, 2019, Clinical Cancer Research.

The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy

P. Bartenstein, E. Wagner, P. Nelson, 2022, EJNMMI Research.

The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy

P. Bartenstein, E. Wagner, P. Nelson, 2022, EJNMMI Research.

Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma

E. Wagner, P. Nelson, R. Glass, 2022, Molecular therapy oncolytics.

An unusual case of struma ovarii

C. Stief, C. Spitzweg, Carolin Kitzberger, 2021, Endocrinology, diabetes & metabolism case reports.

Regional hyperthermia enhances mesenchymal stem cell recruitment to tumor stroma: Implications for mesenchymal stem cell-based tumor therapy.

S. Ziegler, E. Wagner, P. Nelson, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice

E. Wagner, R. Glass, C. Spitzweg, 2023, Molecular therapy oncolytics.